General Information of Drug (ID: DM8H3ZH)

Drug Name
AK002
Indication
Disease Entry ICD 11 Status REF
Urticaria EB00-EB05 Phase 2 [1]
Cross-matching ID
TTD ID
D0TI4C

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)